UnknownNCT01221883
Prevention of PTSD (PTSD) With Diazepam
Medication studyAges 18–67Israel
Understand this study
Who could participate?
Listed age limits: 18 years to 67 years.
- Listed locations
- JerusalemSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2013
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 40
- Sponsor
- Hadassah Medical Organization
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Israel
- Age range
- From 18 Years to 67 Years
- Official registry ID
- NCT01221883
- Official title
Show the full official title
Early Pharmacological Intervention With Diazepam in the Emergency Room Setting to Prevent Posttraumatic Stress Disorder (PTSD).
Recruitment & locations
Status unknownJerusalem
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Hadassah Medical Organization.
Does this study involve medication?
Yes. The study involves medication, including Diazepam.
Who can participate?
Listed age limits: 18 years to 67 years.
